Estechpharma to expand aceclofenac export

Published: 2008-09-25 06:44:00

Updated: 2008-09-25 06:44:00

EstechPharma is making its full efforts to expand its market share in the European market as its aceclofenac has been additionally approved by EDQM (European Directorate for the Quality of Medicines) through on-inspection last October, following the approval of acamprosate in June.

With the ED...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK